Global Markets on Infectious Diseases
Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.
- Mechanism of action of virus
- Prevention and control of virus
- Rabies
- Malaria, Dengue fever, River blindness
- Available vaccines
Related Conference of Global Markets on Infectious Diseases
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
Global Markets on Infectious Diseases Conference Speakers
Recommended Sessions
- Immunology of Infections
- Advancements in Vaccines and Therapeutics
- Antimicrobials/Antibiotics/Antibacterial
- Bacterial Infectious Diseases
- Blood infectious Diseases
- Dental and Oral Infectious Diseases
- Ebola and Zika Viral Infections
- Fungal Infectious Diseases
- Global Markets on Infectious Diseases
- HIV/AIDS and Sexually Transmitted Infections
- Infection Control And Public Health Awareness
- Infectious Diseases
- Infectious Diseases Epidemiology
- Molecular Diagnosis and Treatment of Infectious Diseases
- Most Common NTDs Causes and Treatments
- Neglected Tropical Diseases
- Neuro Infectious Diseases
- Nosocomial Infections & Control
- Pediatric Infectious Diseases
- Tropical Medicine and Immunization Vaccination
- Veterinary Infectious Diseases
- Viral Infectious Diseases
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)

